MLH1 deletion

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

MLH1 deletion	Endometrial Adenocarcinoma	MLH1 deletion	Endometrial Adenocarcinoma	nivolumab Sensitive: C3 – Early Trials nivolumab Sensitive : C3	nivolumab Sensitive: C3 – Early Trials nivolumab Sensitive : C3
MLH1 deletion	Prostate Cancer	MLH1 deletion	Prostate Cancer	nivolumab Sensitive: C3 – Early Trials nivolumab Sensitive : C3	nivolumab Sensitive: C3 – Early Trials nivolumab Sensitive : C3
MLH1 deletion	Colon Cancer	MLH1 deletion	Colon Cancer	cetuximab Resistant: D – Preclinical cetuximab Resistant : D	cetuximab Resistant: D – Preclinical cetuximab Resistant : D

Associations